Summary Safety Review - Hydroxyzine (ATARAX and generics) - Assessing the Potential Risk of Abnormal Heart Rhythm
Summary Safety Review - Hydroxyzine (ATARAX and generics) - Assessing the Potential Risk of Abnormal Heart Rhythm is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2024-05-09. On CanQuery you can follow the original downloads. Files are available in English and French.
A safety review was undertaken soon after the European Medicines Agency notified Health Canada of the possibility that the use of hydroxyzine products could be associated with abnormal changes in the electrical activity of the heart, such as QT interval prolongation.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2024-05-09
Data overview
- Formats
- HTML
- File languages
- English, French